Sun H Kim, Ipsa Arora, Charles Agyemang, Ranjit M Anjana, Bjørn Olav Åsvold, Marieke Blom, Shilpa N Bhupathiraju, Amélie Bonnefond, Juliana C N Chan, Timothy M E Davis, Kristian Hveem, Marit E Jørgensen, Anton Lager, Lars Lind, Olle Melander, Andrea Natali, Jackie Price, Parminder Raina, Michael Roden, Olov Rolandsson, Mary R Rooney, Seyed Mohammad Mousavi, Andrei C Sposito, Reimar W Thomsen, Barbara Thorand, Rob M Van Dam, Kavita Venkataraman, Sarah H Wild, Ji Hee Yu, Petra J M Elders, Joline W Beulens, Femke Rutters
This narrative review provides a historical perspective on how observational research on type 2 diabetes has been developed and consolidated over the last 50 years and how well-designed cohort studies will provide us with knowledge for research and practice in the future and aid guideline development. We have included data from a large number of cohorts from every continent that have been used to study the development and/or progression of type 2 diabetes, including cohorts that are general population-based, disease-based, intervention-based and registry-based. We have structured the results from the past 50 years based on the following themes: diagnosis and screening, complications, risk factors and pathophysiology. We also discuss the strengths and weaknesses of observational research when compared with other research designs. Finally, we discuss the emerging and future directions for type 2 diabetes research using cohorts, which include novel developments, such as artificial intelligence, precision health and the exposome. We conclude that cohort research has significantly advanced our understanding of type 2 diabetes and aided guideline development, and complements experimental work, such as human randomised controlled trials and animal studies. Both approaches are essential and complementary in our pursuit to provide a more comprehensive understanding of the development and progression of type 2 diabetes, and to change dogma, practice and policies for better outcomes.